Correlation Between Design Therapeutics and Orgenesis
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Orgenesis, you can compare the effects of market volatilities on Design Therapeutics and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Orgenesis.
Diversification Opportunities for Design Therapeutics and Orgenesis
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Design and Orgenesis is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Orgenesis go up and down completely randomly.
Pair Corralation between Design Therapeutics and Orgenesis
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.63 times more return on investment than Orgenesis. However, Design Therapeutics is 1.58 times less risky than Orgenesis. It trades about 0.04 of its potential returns per unit of risk. Orgenesis is currently generating about -0.03 per unit of risk. If you would invest 559.00 in Design Therapeutics on August 31, 2024 and sell it today you would earn a total of 41.00 from holding Design Therapeutics or generate 7.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 92.78% |
| Values | Daily Returns |
Design Therapeutics vs. Orgenesis
Performance |
| Timeline |
| Design Therapeutics |
| Orgenesis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Design Therapeutics and Orgenesis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Orgenesis
The main advantage of trading using opposite Design Therapeutics and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.| Design Therapeutics vs. Cue Biopharma | Design Therapeutics vs. Eliem Therapeutics | Design Therapeutics vs. Inhibrx | Design Therapeutics vs. Molecular Partners AG |
| Orgenesis vs. Tff Pharmaceuticals | Orgenesis vs. Quoin Pharmaceuticals Ltd | Orgenesis vs. Aerovate Therapeutics | Orgenesis vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |